Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108047118A reveals a green, metal-free route for high-purity 3-indoleselenyl alcohol intermediates, offering substantial cost and supply chain advantages.
Patent CN102229561B details a green one-step copper-catalyzed cyclization for high-purity pharmaceutical intermediates, offering significant cost and supply chain advantages.
Patent CN105037274B enables continuous benzimidazole production. High yield, reduced waste, reliable supply chain for pharmaceutical intermediates.
Novel copper acetate method for coumarin synthesis offers cost reduction and mild conditions for optoelectronic material manufacturing supply chains.
Patent CN115197256B reveals ligand-free manganese catalysis for organoboron synthesis offering substantial cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN107098936B reveals a novel crown ether-catalyzed hydrolysis for TAF intermediates, offering superior purity and supply chain reliability for pharmaceutical manufacturers.
Novel enzymatic route for Finerenone intermediates reduces heavy metal risk and cost significantly. Ideal for reliable pharmaceutical intermediate supplier partnerships seeking green chemistry.
Patent CN118638002A details a green synthesis route for 2-propyl-4-pentenoic acid, offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN104693162B reveals mild Cu-catalyzed route. Enhances supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN109988143A reveals green synthesis route. Offers high purity and cost efficiency for pharmaceutical intermediates. Reliable supply chain partner for scale-up.
Patent CN108017579A details metal-free quinoline synthesis via visible light. Offers high purity, mild conditions, and scalable supply chain solutions for global pharmaceutical manufacturers.
Patent CN116444345B reveals green ionic liquid method for fluorenyl diol. High yield, recyclable catalyst ensures supply chain stability and cost efficiency.
Novel visible-light driven synthesis method offers mild conditions and high purity for pharmaceutical intermediates, ensuring supply chain reliability and cost efficiency.
Patent CN101962391B discloses a novel chiral phosphine catalyst offering high enantioselectivity for nitrile cyanosilylation, ensuring reliable supply chain solutions.
Advanced synthesis of entecavir intermediate via novel iron-catalyzed Friedel-Crafts alkylation. Offers superior purity, cost efficiency, and scalable supply chain solutions.
Patent CN105330608A reveals high-ee urazole synthesis. Enables cost reduction in chiral catalyst manufacturing and reliable supply chain for pharma intermediates.
Novel photocatalyst-free method for high-purity homoallylamine intermediates using water and visible light, ensuring cost-effective and scalable manufacturing.
Patent CN110818600B details a green Ag-catalyzed method for beta-carbonyl sulfones. Offers high yield, mild conditions, and scalable pharma intermediate production.
Patent CN105461606A reveals enzymatic hydrolysis for Ledipasvir intermediates. Achieve >99% de purity and scalable green manufacturing for Hepatitis C drug supply chains.
Patent CN107936007A details a water-catalyzed synthesis for lurasidone hydrochloride offering cost reduction and supply chain reliability for pharmaceutical intermediates.